Platelet Aggregation Devices Market Report by Product (Systems, Reagents, Consumables and Accessories), Type (Four Channel, Dual Channel, Eight Channel), Application (Clinical Applications, Research Applications, Cardiovascular Applications, Orthopedic Applications, and Others), End User (Hospitals, Diagnostic Laboratories, Research and Academic Institutes, and Others), and Region 2026-2034

Platelet Aggregation Devices Market Report by Product (Systems, Reagents, Consumables and Accessories), Type (Four Channel, Dual Channel, Eight Channel), Application (Clinical Applications, Research Applications, Cardiovascular Applications, Orthopedic Applications, and Others), End User (Hospitals, Diagnostic Laboratories, Research and Academic Institutes, and Others), and Region 2026-2034

Report Format: PDF+Excel | Report ID: SR112026A4613

Market Overview:

The global platelet aggregation devices market size reached USD 613.5 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 937.6 Million by 2034, exhibiting a growth rate (CAGR) of 4.68% during 2026-2034.

Report Attribute
Key Statistics
Base Year
2025
Forecast Years
2026-2034
Historical Years
2020-2025
Market Size in 2025 USD 613.5 Million
Market Forecast in 2034 USD 937.6 Million
Market Growth Rate (2026-2034) 4.68%

Platelet aggregation devices comprise adenosine-diphosphate (ADP), thrombin, and ristocetin-induced platelet aggregation (RIPA). These devices are used to diagnose patients with inherited and acquired platelet function disorders, such as excessive bleeding, arterial thrombotic, stroke, and myocardial infarction. They assist in transfusing medicines, pre-surgery tests, and clinical settings to monitor the response of antiplatelet therapies and assess perioperative bleeding risk. At present, due to the launch of new potential biomarkers and technologies, platelet aggregation devices are finding extensive application in personalizing antiplatelet drugs and monitoring the efficacy of various types of pro-hemostatic therapies around the world.

Platelet Aggregation Devices Market Size

To get more information on this market Request Sample

Platelet Aggregation Devices Market Trends:

The rising instances of platelet aggregation among patients diagnosed with coronavirus disease (COVID-19) are strengthening the growth of the market. Moreover, due to the growing prevalence of colon cancer, cardiovascular diseases, Kawasaki condition, acute coronary syndrome (ACS), acute ischemic stroke, and acute rheumatic disorders across the globe, there is an increase in the risk of bleeding. This acts as another key factor impelling the growth of the platelet aggregation devices market for clinical management of platelet function disorders. In addition, a significant rise in the aging population suffering from chronic diseases is contributing to the market growth. Apart from this, leading manufacturers are launching novel products to expand their product portfolio and retain a competitive edge in the market. They are also focusing on developing new and simpler point-of-care (POC) diagnostic devices. These devices rely on the latest methodologies for helping in the rapid evaluation of inherited and acquired bleeding disorders and antiplatelet therapies. This, coupled with the increasing need for POC diagnostic devices to fulfill the healthcare demand of the large population, is projected to drive the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global platelet aggregation devices market report, along with forecasts at the global, regional and country level from 2026-2034. Our report has categorized the market based on product, type, application and end user.

Breakup by Product:

  • Systems
  • Reagents
  • Consumables and Accessories
     

Breakup by Type:

  • Four Channel
  • Dual Channel
  • Eight Channel
     

Breakup by Application:

Platelet Aggregation Devices Market By Application

Access the comprehensive market breakdown Request Sample

  • Clinical Applications
  • Research Applications
  • Cardiovascular Applications
  • Orthopedic Applications
  • Others
     

Breakup by End User:

  • Hospitals
  • Diagnostic Laboratories
  • Research and Academic Institutes
  • Others
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Aggredyne Inc., Chrono-Log Corporation, F. Hoffmann-La Roche AG, Grifols S.A., Hart Biologicals Ltd., Helena Laboratories Corporation, LAbor BioMedical Technologies GmbH, Matis Medical Inc., Sentinel Ch. S.P.A., Siemens AG, Sienco Inc., Sysmex Corporation and WerfenLife SA.

Report Coverage:

Report Features Details
Base Year of the Analysis 2025
Historical Period 2020-2025
Forecast Period 2026-2034
Units Million USD
Segment Coverage Product, Type, Application, End User, Region
Region Covered Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Aggredyne Inc., Chrono-Log Corporation, F. Hoffmann-La Roche AG, Grifols S.A., Hart Biologicals Ltd., Helena Laboratories Corporation, LAbor BioMedical Technologies GmbH, Matis Medical Inc., Sentinel Ch. S.P.A., Siemens AG, Sienco Inc., Sysmex Corporation and WerfenLife SA
Customization Scope 10% Free Customization
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Key Questions Answered in This Report

The global platelet aggregation devices market was valued at USD 613.5 Million in 2025.

We expect the global platelet aggregation devices market to exhibit a CAGR of 4.68% during 2026-2034.

The sudden outbreak of the COVID-19 pandemic has led to the increasing demand for platelet aggregation devices for treating platelet aggregation disorder, that is caused as a side-effect among the coronavirus-infection patients.

The rising prevalence of various chronic diseases, such as cardiovascular disorders, colon cancer, Kawasaki condition, etc., along with the growing adoption of platelet aggregation devices for clinical management of platelet function disorders, is primarily driving the global platelet aggregation devices market.

Based on the product, the global platelet aggregation devices market has been divided into systems, reagents, and consumables and accessories. Among these, reagents currently exhibit a clear dominance in the market.

Based on the type, the global platelet aggregation devices market can be categorized into four channel, dual channel, and eight channel. Currently, four channel accounts for the majority of the global market share.

Based on the application, the global platelet aggregation devices market has been segregated into clinical applications, research applications, cardiovascular applications, orthopedic applications, and others, where clinical applications currently hold the largest market share.

Based on the end user, the global platelet aggregation devices market can be bifurcated into hospitals, diagnostic laboratories, research and academic institutes, and others. Currently, hospitals exhibit a clear dominance in the market.

On a regional level, the market has been classified into North America, Asia Pacific, Europe, Latin America, and Middle East and Africa, where North America currently dominates the global market.

Some of the major players in the global platelet aggregation devices market include Aggredyne Inc., Chrono-Log Corporation, F. Hoffmann-La Roche AG, Grifols S.A., Hart Biologicals Ltd., Helena Laboratories Corporation, LAbor BioMedical Technologies GmbH, Matis Medical Inc., Sentinel Ch. S.P.A., Siemens AG, Sienco Inc., Sysmex Corporation, and WerfenLife SA.

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Platelet Aggregation Devices Market Report by Product (Systems, Reagents, Consumables and Accessories), Type (Four Channel, Dual Channel, Eight Channel), Application (Clinical Applications, Research Applications, Cardiovascular Applications, Orthopedic Applications, and Others), End User (Hospitals, Diagnostic Laboratories, Research and Academic Institutes, and Others), and Region 2026-2034
Purchase Options Discount
Offer
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-201-971-6302

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials